DuweA.K., VasS.I., WeatherheadJ.W., Effects of the composition of peritoneal dialysis fluid on chemilumi-nescence, phagocytosis, and bactericidal activity in vitro.Infect Immun1981; 33: 130–5.
2.
JörresA., GahlG.M., FreiU.Peritoneal dialysis fluid biocompatibility: does it really matter?Kidney Int Suppl1994; 48: S79–86.
3.
JörresA., GahlG.M., TopleyN.In vitro-biocompatibility of alternative CAPD fluids; comparison of bicarbona te-buffered and gl ucose-polymer-based solutions.Nephrol Dial Transplant1994; 9: 785–90.
4.
TopleyN., KaurD., PetersenM.M.Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.Kidney Int1996; 49: 1447–56.
5.
FerianiM., Passlick-DeetjenJ., KirchgessnerJ.Long term safety and efficacy of bicarbonate buffered peritoneal dialysis solutions (Abstract).Nephrol Dial Transplant1996; 11: A253.
6.
VeechR.L.The metabolism of lactate.NMR Biomed1991; 4: 53–8.
7.
TopleyN., KaurD., PetersenM.M.In vitro effects of bicarbonate and bicarbonate-Iactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.J Am Soc Nephrol1996; 7: 218–24.
BrunkhorstR., MahioutA.Pyruvate neutralizes perito neal dialysate toxicity: maintained integrity and proliferation of cultured human mesothelial cells.Kidney Int1995; 48: 177–81.
10.
LiberekT., TopleyN., JörresA.Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.Nephron1993; 65: 260–5.
